Jena/Germany, Munich/Germany | 29 October 2018 | Carl Zeiss Microscopy GmbH
ZEISS and arivis have now expanded and deepened their cooperation, which began in 2014. The companies are pursuing the common goal of enabling new findings in life sciences and in materials research by improving the presentation and analysis of digital data.
Modern microscope systems with high-resolution optics record ever increasing amounts of data, which can only be displayed and analyzed with the help of advanced software. This requires powerful algorithms and applications that allow these very large, complex multidimensional data to be displayed without delay and evaluated automatically.
Within the framework of the partnership, arivis will continuously develop the 4D visualization solution already integrated into the ZEISS software. Furthermore, ZEISS will offer high-end software products from arivis together with 3D microscopy systems to better address customer applications. Thus it is becoming possible for users of such systems to quantitatively evaluate multidimensional image data in highest quality and reliability.
Furthermore, arivis and ZEISS have agreed to jointly advance new developments and to further optimize the interaction between hardware and software in a user-friendly manner. arivis will also contribute its expertise in the areas of virtual reality and web-sharing technologies and, together with ZEISS, continue to shape future developments for 3D applications in academic and industrial research as well as quality assurance.
ZEISS and arivis are also cooperating on the new cloud-based digital microscopy platform APEER, the first version of which was recently presented to the public. arivis is implementing the visualization of the platform.
APEER combines various microscopic applications, especially for the further processing of images such as 3D reconstructions, staining and segmentation, and serves as an exchange platform. This gives microscopy users more time for research.
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. The ZEISS Group develops, produces and distributes measuring technology, microscopes, medical technology, eyeglass lenses, camera and cinema lenses, binoculars and semiconductor manufacturing equipment. With its solutions, the company constantly advances the world of optics and helps shape technological progress. ZEISS is divided up into the four segments Industrial Quality & Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology. The ZEISS Group is represented in more than 40 countries and has over 50 sales and service locations, more than 30 manufacturing sites and about 25 research and development centers around the globe.
In fiscal year 2016/17 the company generated revenue approximating €5.3 billion with around 27,000 employees. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. Carl Zeiss AG is the strategic management holding company that manages the ZEISS Group. The company is wholly owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).
Further information at www.zeiss.com
ZEISS Research Microscopy Solutions is the world's only one-stop manufacturer of light, electron, X-ray and ion microscope systems and offers solutions for correlative microscopy. The portfolio comprises products and services for the life sciences and materials research as well as for industry, education and clinical practice. The unit is headquartered in Jena. Additional production and development sites are located in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK, and in Peabody, MA and Pleasanton, CA in the USA. ZEISS Research Microscopy Solutions is allocated to the Industrial Quality & Research segment. Around 6,300 employees work for the segment, generating revenue totaling €1.5 billion in fiscal year 2016/17.
arivis develops and provides IT solutions focused on the Life Sciences. Our product portfolio ranges from solutions in science, regulatory, production to quality assurance for medical and pharmaceutical products.
arivis is a market leading software company focused on the life sciences industry. With a broad product portfolio, our solutions address industry and academic environments. We offer software solutions as well as services provided by our experienced IT project engineers and experienced subject matter experts.
Headquartered in Munich, arivis is an international fast-growing company that already generates more than 50% of its revenue in more than 25 countries outside of Germany. Especially in the USA arivis has built up a broad customer base and expects exponential further growth. In the US the company is headquartered in Phoenix (AZ), with a further office near Washington (D.C.).
More information at www.arivis.com